Inhalation & Respiratory Drug Delivery USA Congress

  • Check with publisher
  • Published date: August 9, 2017
    • San Diego, California, United States

Oxford Global Conferences are proud to present our Inhalation & Respiratory Drug Delivery USA Congress, 12 – 13 March 2018, San Diego, USA with our co-located Formulation & Drug Delivery USA Congress. Across the two days, over 200 senior industry experts will present new trends in combination product design and the future directions of inhalation drug delivery research. Further discussion will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.

Including 2 interactive streams:

• Development & Formulation of Inhaled Therapies
• Inhalation Devices & Analytics

Download Agenda: http://bit.ly/2vM0wXu

Free Webinar Recording

Inhaled Insulin: Highway to Heaven or Road to Ruin?
Hosted by Jim Fink, Senior Fellow Clinical Aerosol Product Development, Dance Biopharm
Download for Free Today: http://bit.ly/2f80t4t

Stratification and Considerations for DPI Development
Hosted by Sven Stegemann, Professor, Graz University of Technology
Download for Free Today: http://bit.ly/2u3vyNo

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

Result 0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-FOLR1-S-S-Dox ADC

    Anti-FOLR1-S-S-Dox ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-folr1-47.htm This ADC product is comprised of an anti-FOLR1 monoclonal antibody conjugated via a linker to Dox. The Dox is targeted to certain cancers by immunerecognition and delivered into cancer cells vi...

  • Anti-FOLR1 (clone M9346A)-sulfo-SPDB-DM4 ADC

    Anti-FOLR1 (clone M9346A)-sulfo-SPDB-DM4 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-folr1-47.htm This ADC product is comprised of an anti-FOLR1 monoclonal antibody (clone M9346A)conjugated via a sulfo-SPDB linker to a DM4. The DM4 is targeted to certain cancers by immunerecognition and del...

  • Anti-FOLR1-DGN462 ADC

    Anti-FOLR1-DGN462 ADC

    Drug Development Shirley (New York) December 15, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-folh1-46.htm This ADC product is comprised of an anti-FOLR1 monoclonal antibody conjugated via a linker to DGN462. The DGN462 is targeted to certain cancers by immunerecognition and delivered into cancer ce...